Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
Mark Christopher Markowski, M.D., Ph.D.
Instructor of Oncology
Expertise: General Internal Medicine, Medical Oncology, Prostate Cancer
Research Interests: Anti-inflammatory agents and cancer incidence
Dr. Mark Markowski is a medical oncologist with the Sidney Kimmel Cancer Center at Sibley Memorial Hospital. A skilled medical oncologist treating numerous types of cancers, he participates in multidisciplinary clinics at Sibley Memorial Hospital as well as at The Johns Hopkins Hospital, and sees patients in the genitourinary clinics of both hospitals. In addition to his patient care services, Dr. Markowski is also a researcher and instructor. Dr. Markowski's major area of research interest is in early phase drug development for prostate cancer.
Dr. Markowski completed both his B.S. (in biochemistry) and his M.D./Ph.D at Georgetown University. He completed his residency in Internal Medicine at Columbia University in New York City, and his Medical Oncology Fellowship training at Johns Hopkins Hospital.
- Instructor of Oncology
Departments / Divisions
- Medicine at Sibley Memorial Hospital
- Oncology - Prostate Cancer and GU
- MD, Georgetown University School of Medicine (2009)
- New York Presbyterian Hospital - Cornell Campus / Internal Medicine (2012)
- Johns Hopkins University School of Medicine / Medical Oncology (2017)
- American Board of Internal Medicine / Internal Medicine (2012)
- Pending/Scheduled / Medical Oncology
Research & Publications
Selected PublicationsView all on Pubmed
Kass DJ, Rattigan E, Kahloon R, Loh K, Yu L, Savir A, Markowski M, Saqi A, Rajkumar R, Ahmad F, Champion HC. Early treatment with fumagillin, an inhibitor of methionine aminopeptidase-2, prevents Pulmonary Hypertension in monocrotaline-injured rats. PLoS One. 2012;7(4):e35388. doi: 10.1371/journal.pone.0035388. Epub 2012 Apr 11. PMID: 22509410